The novel treatment of the medication represents a exciting breakthrough in the care of diabetes mellitus type 2. Unlike existing medications, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide545759.onesmablog.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-83495112